BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30046846)

  • 21. Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Sin Y; Akane S; Sugaya J; Mori T; Fukushima S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2021 Nov; 34(6):1899-1910. PubMed ID: 34304386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Giant cell tumor of bone-an update].
    Tschavoll F; Lutteri G; Leinauer B; Mellert K; Möller P; Barth TFE
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):215-219. PubMed ID: 37985483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.
    Noh BJ; Park YK
    Hum Pathol; 2018 Nov; 81():1-8. PubMed ID: 29944971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Utility of Genetic and Immunohistochemical
    Wągrodzki M; Tysarowski A; Seliga K; Wojnowska A; Stepaniuk M; Castañeda Wysocka P; Makuła D; Pieńkowski A; Szostakowski B; Zub R; Rutkowski P
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability and Role of Mutation-specific H3F3A (Histone 3-3) G34W Immunohistochemistry to Differentiate Giant Cell Tumor of Bone From its Clinicoradiologic and Histologic Mimics: An Institutional Study.
    Pasricha S; Pruthi M; Jajodia A; Kumar A; Gupta G; Sharma A; Tiwari A; Rohela H; Durga G; Kamboj M; Koyyala VPB; Mehta A
    Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):36-41. PubMed ID: 34347625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.
    Kamble A; Hui M; Rao KN; Narayanan R; Reddy BR; Uppin SG; Chandrasekhar P
    Indian J Pathol Microbiol; 2022; 65(3):617-629. PubMed ID: 35900490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone.
    Ono T; Noguchi R; Yoshimatsu Y; Tsuchiya R; Sin Y; Nakagawa R; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2022 Jan; 35(1):392-399. PubMed ID: 34731453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic lockdown of CDKN1A (p21) and CDKN2A (p16) characterises the neoplastic spindle cell component of giant cell tumours of bone.
    Giesche J; Mellert K; Geißler S; Arndt S; Seeling C; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TF
    J Pathol; 2022 Aug; 257(5):687-696. PubMed ID: 35522566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR).
    Gamberi G; Morandi L; Benini S; Resca A; Cocchi S; Magagnoli G; Donati DM; Righi A; Gambarotti M
    Pathol Res Pract; 2018 Jan; 214(1):89-94. PubMed ID: 29254795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach.
    Kervarrec T; Collin C; Larousserie F; Bouvier C; Aubert S; Gomez-Brouchet A; Marie B; Miquelestorena-Standley E; Le Nail LR; Avril P; Christophe Pagès J; de Pinieux G
    Mod Pathol; 2017 Mar; 30(3):393-406. PubMed ID: 28059095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location.
    Scotto di Carlo F; Divisato G; Iacoangeli M; Esposito T; Gianfrancesco F
    BMC Cancer; 2018 Apr; 18(1):358. PubMed ID: 29609578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.
    Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V
    Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The study of the value of H3F3A G34W immunohistochemical staining in the diagnosis of giant cell tumor of bone].
    Bai YQ; Yang TT; Zhang HZ
    Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):531-536. PubMed ID: 31288308
    [No Abstract]   [Full Text] [Related]  

  • 34. [New aspects on giant cell tumor of bone].
    Lüke J; Hasenfratz M; Möller P; Barth TFE
    Pathologe; 2018 Mar; 39(2):125-131. PubMed ID: 29110035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
    Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
    Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of Bone.
    Miskad UA; Syamsul F; Dahlan H; Sungowati NK; Achmad D; Johan MP
    Asian Pac J Cancer Prev; 2023 May; 24(5):1737-1741. PubMed ID: 37247296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone Mutations and Bone Cancers.
    Taylor EL; Westendorf JJ
    Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
    Girolami I; Mancini I; Simoni A; Baldi GG; Simi L; Campanacci D; Beltrami G; Scoccianti G; D'Arienzo A; Capanna R; Franchi A
    J Clin Pathol; 2016 Mar; 69(3):240-7. PubMed ID: 26338802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locally Aggressive Giant Cell Tumor of Bone With Pulmonary Distant Metastasis and Extrapulmonary Seeding in Pregnancy.
    Murshed KA; Elsayed AM; Szabados L; Rashid S; Ammar A
    J Am Acad Orthop Surg Glob Res Rev; 2020 Jan; 4(1):. PubMed ID: 32159067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The malignant transformation after denosumab-treated giant cell tumor of bone and the H3F3A mutation syndrome].
    Gong LH; Liu WF; Shan HC; Sun XQ; Zhang M; Ding Y; Niu XH
    Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1177-1179. PubMed ID: 33152826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.